作者: Connie Celum , Jared M. Baeten
DOI: 10.1097/QCO.0B013E32834EF5EF
关键词: Tenofovir 、 Pre-exposure prophylaxis 、 Medicine 、 Pharmacology 、 MEDLINE 、 Medication adherence 、 Human immunodeficiency virus (HIV) 、 Internal medicine
摘要: Purpose of reviewTopical tenofovir gel and oral emtricitabine–tenofovir [FTC/tenofovir disoproxyl fumarate (TDF)] have been demonstrated to efficacy in preventing HIV-1 some populations. Preexposure prophylaxis (PrEP) trials future directions are summarized.Recent findingsP